talquetamab,ibrutinib
abbvie,janssen
[' ibru', 'mantle,(-dismantle)', 'multiple myeloma', 'talquetamab', 'lymphoma']
catch up with nejm group's weekend coverage of #ash22:
- talquetamab for relapsed or refractory multiple myeloma
- adding ibrutinib to mantle-cell lymphoma treatment
- inequities in pulmonary embolism management and mortality 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.